ICL Group (ICL) Q3 2025 earnings summary

Executive summary

• Q3 2025 sales reached $1.9B, up 6% year-over-year, with adjusted EBITDA rising 4% to $398M and adjusted diluted EPS at $0.10.

• Net income attributable to shareholders was $129M, with adjusted net income at $124M.

• Strategic focus shifted to specialty crop nutrition and food solutions, with portfolio optimization and cost efficiency prioritized.

• Discontinued downstream LFP battery materials projects in St. Louis and Spain due to market and policy changes.

• Signed MOU with Israeli government for Dead Sea concession, providing regulatory clarity and reducing business risks.

Financial highlights

• Q3 2025 sales: $1,853M vs. $1,753M in Q3 2024; adjusted EBITDA: $398M, up from $383M in 3Q'24.

• Gross profit: $604M (33% margin), operating income: $230M (12% margin), adjusted operating income: $241M.

• Adjusted net income: $124M; diluted EPS steady at $0.09, adjusted diluted EPS at $0.10.

• Cash flows from operating activities: $308M; available liquidity: $1.5B.

• Dividend declared: $62M (4.80 cents/share), with an annual yield of 2.8%.

Outlook and guidance

• Full-year 2025 specialties-driven EBITDA expected between $0.95B and $1.15B.

• Potash sales volumes forecasted at 4.3M–4.5M metric tons, with an annual tax rate of ~30%.

• Guidance maintained as of November 12, 2025.